Financhill
Back

Akoustis Technologies Vs. PTC Therapeutics Industry Stock Comparison

Sell
19

AKTS
Akoustis Technologies

Last Price:
0.12
Seasonality Move:
-10.43%
Sell
35

PTCT
PTC Therapeutics

Last Price:
30.60
Seasonality Move:
8.11%
Sell
19
Akoustis Technologies (AKTS) is a Sell

Is Akoustis Technologies a Buy, Sell or Hold?

  • The current Akoustis Technologies [AKTS] share price is $0.13. The Score for AKTS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • AKTS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
PTC Therapeutics (PTCT) is a Sell

Is PTC Therapeutics a Buy, Sell or Hold?

  • The current PTC Therapeutics [PTCT] share price is $31.00. The Score for PTCT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKTS Stock Price Chart

What is Akoustis Technologies's stock price today?

  • The Akoustis Technologies share price today is $0.13
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKTS is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTCT Stock Price Chart

What is PTC Therapeutics's stock price today?

  • The PTC Therapeutics share price today is $31.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTCT is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKTS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 35.32 Sell
Chaikin Money Flow: 2544106 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.12 - 0.18) Sell
Bollinger Bands (100): (0.25 - 0.67) Sell

PTCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.95 Sell
Relative Strength Index (14 RSI): 38.05 Sell
Chaikin Money Flow: 242921 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.07 - 37.67) Sell
Bollinger Bands (100): (26.88 - 35.22) Sell

AKTS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.13 Sell
20-day SMA: 0.14 Sell
50-day SMA: 0.3 Sell
200-day SMA: 0.57 Sell
8-day EMA: 0.13 Sell
20-day EMA: 0.16 Sell
50-day EMA: 0.27 Sell
200-day EMA: 0.8 Sell

PTCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.97 Sell
20-day SMA: 35.08 Sell
50-day SMA: 34.11 Sell
200-day SMA: 27.6 Buy
8-day EMA: 32.46 Sell
20-day EMA: 34.04 Sell
50-day EMA: 33.6 Sell
200-day EMA: 31.79 Sell

Akoustis Technologies Earnings Growth & AKTS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.35 per share.

PTC Therapeutics Earnings Growth & PTCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.53 per share, and an increase next year of $2.47 per share.

Akoustis Technologies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

PTC Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):